Form 4: Arcutis Biotherapeutics Director Keith Leonard Reports Acquisition of Shares and Stock Options

Director Keith Leonard reports acquisition of Arcutis Biotherapeutics shares and stock options related to his service as a non-employee director.

Summary

• Keith Leonard, a director of Arcutis Biotherapeutics, reported acquiring 10,139 shares of common stock and 27,052 stock options on June 14, 2024.
• The shares were granted as Restricted Stock Units (RSUs) in connection with his service as a non-employee director.
• The RSUs vest in full on the one-year anniversary of the grant date, subject to continuous service.
• The stock options have an exercise price of $8.63 and also vest 100% on the first anniversary of June 14, 2024, subject to continuous service.
• Leonard also indirectly owns 1,750 shares through the Leonard Family Trust.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The sentiment is neutral, reflecting standard compensation practices.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The RSUs and stock options vest based on continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's stock. This filing indicates compensation and alignment of interests between the director and shareholders.

Comparison to Industry Standards

• Director compensation packages often include stock options and RSUs to align their interests with shareholders, similar to practices at companies like Amgen (AMGN) and Regeneron (REGN).
• The vesting schedules are typical, with full vesting after one year of service, which is comparable to industry standards for director equity grants at companies such as Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD).

Stakeholder Impact

• The acquisition of shares and options by a director can positively influence shareholder sentiment, indicating confidence in the company's prospects.

Key Dates